Kelly J Yu

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, 6120 Executive Boulevard, Suite 550, Bethesda, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 16:2504-8. 2007
  2. ncbi Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20852, USA
    Int J Cancer 124:1622-5. 2009
  3. ncbi CD83 polymorphisms and cervical cancer risk
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20852, USA
    Gynecol Oncol 114:319-22. 2009
  4. ncbi Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    Hum Immunol 70:910-4. 2009
  5. ncbi Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, USA
    Clin Cancer Res 17:1906-14. 2011
  6. ncbi Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma
    Cindy Chang
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20892, USA
    J Med Virol 85:524-9. 2013
  7. ncbi The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal
    Cindy M Chang
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7074, Rockville, MD 20892, USA
    Virus Res 143:209-21. 2009

Detail Information

Publications7

  1. ncbi Evaluation of the association with cervical cancer of polymorphisms in syndecan-1, a heparan sulfate proteoglycan involved with viral cell entry
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, 6120 Executive Boulevard, Suite 550, Bethesda, MD 20852, USA
    Cancer Epidemiol Biomarkers Prev 16:2504-8. 2007
    ..S. Study. Our results indicate a lack of association between SDC-1 polymorphisms and risk of squamous cell carcinomas of the cervix. An association between SDC-1 Pro-27 polymorphism and cervical adenocarcinoma cannot be ruled out...
  2. ncbi Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20852, USA
    Int J Cancer 124:1622-5. 2009
    ..0. Analysis of the largest NPC multiplex family study to date confirms the presence of coaggregation of NPC within families in Taiwan but does not provide evidence for a broader familial syndrome involving NPC and other tumors...
  3. ncbi CD83 polymorphisms and cervical cancer risk
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20852, USA
    Gynecol Oncol 114:319-22. 2009
    ....
  4. ncbi Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
    Hum Immunol 70:910-4. 2009
    ..This finding requires replication in larger studies...
  5. ncbi Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families
    Kelly J Yu
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, Maryland, USA
    Clin Cancer Res 17:1906-14. 2011
    ..We examined the risk associated with EBV markers and their clinical utility to identify NPC susceptibles within high-risk NPC families...
  6. ncbi Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma
    Cindy Chang
    Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20892, USA
    J Med Virol 85:524-9. 2013
    ..In conclusion, a large number of EBV markers can be measured reliably in serum samples using peptide-based anti-EBV ELISAs...
  7. ncbi The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal
    Cindy M Chang
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7074, Rockville, MD 20892, USA
    Virus Res 143:209-21. 2009
    ....